ibi362
Showing 1 - 9 of 9
Renal Impairment Trial in Beijing (IBI362)
Not yet recruiting
- Renal Impairment
- IBI362
-
Beijing, Beijing, ChinaAerospace Center Hospital
Mar 20, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Obesity Or Overweight Trial in Beijing (Placebo, IBI362)
Recruiting
- Obesity Or Overweight
- Placebo
- IBI362
-
Beijing, ChinaPeople's Hospital of Peking University
Dec 18, 2022
Type 2 Diabetes Trial in Nanjing (, IBI362)
Recruiting
- Type 2 Diabetes
- placebo
- IBI362
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Jan 27, 2023
Type 2 Diabetes Trial in Beijing (dulaglutide, IBI362)
Not yet recruiting
- Type 2 Diabetes
- dulaglutide
- IBI362
-
Beijing, ChinaChina-Japan Friendship Hospital
Nov 1, 2022
Overweight/ Obesity Trial in Beijing (IBI362, )
Recruiting
- Overweight/ Obesity
- IBI362
- placebo
-
Beijing, Beijing, ChinaPeking University people's hospital
Jul 20, 2022
Type 2 Diabetes Trial in Beijing (IBI362, , Dulaglutide)
Active, not recruiting
- Type 2 Diabetes
- IBI362
- +2 more
-
Beijing, Beijing, ChinaChina Japan Friendship Hospital
Jul 15, 2022
Overweight or Obesity Trial in Beijing (IBI362, Placebo)
Active, not recruiting
- Overweight or Obesity
- IBI362
- Placebo
-
Beijing, ChinaPeking University people's hospital
Jul 11, 2021
Type 2 Diabetes Trial in Beijing (IBI362, Placebo, Dulaglutide)
Completed
- Type 2 Diabetes
- IBI362
- +2 more
-
Beijing, ChinaChina Japan Friendship Hospital
Jul 21, 2021